OneMed - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 2,291,337 | 2,354,716 | 3,005,146 | 3,744,306 | 2,699,135 | 2,838,599 | 2,905,952 | 2,987,882 |
| Profit before tax | -16,498 | 28,578 | 458,145 | 349,510 | -188,164 | 33,257 | 39,369 | 56,655 |
| Net profit | -10,961 | 27,516 | 324,074 | 294,344 | -209,900 | 25,111 | 29,407 | 42,089 |
| Equity | 191,420 | 218,936 | 543,010 | 837,354 | 627,454 | 652,565 | 681,972 | 724,061 |
| Liabilities | 503,648 | 544,480 | 347,916 | 436,891 | 468,401 | 667,293 | 404,073 | 69,773 |
| Non-current assets | 79,890 | 82,073 | 15,500 | 5,587 | 11,747 | 9,324 | 7,230 | 6,552 |
| Current assets | 665,564 | 720,371 | 921,278 | 1,296,170 | 1,122,022 | 1,338,902 | 1,090,132 | 824,996 |
| Total assets | 745,454 | 802,444 | 936,778 | 1,301,757 | 1,133,769 | 1,348,226 | 1,097,362 | 831,548 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 468,724 | 434,198 | 372,141 |
| Social insurance contributions | - | - | - | - | - | 43,796 | 46,255 | 54,107 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -7.8% | +2.8% | +27.6% | +24.6% | -27.9% | +5.2% | +2.4% | +2.8% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -1.5% | 3.4% | 34.6% | 22.6% | -18.5% | 1.9% | 2.7% | 5.1% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -5.7% | 12.6% | 59.7% | 35.2% | -33.5% | 3.8% | 4.3% | 5.8% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -0.5% | 1.2% | 10.8% | 7.9% | -7.8% | 0.9% | 1.0% | 1.4% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | -0.7% | 1.2% | 15.2% | 9.3% | -7.0% | 1.2% | 1.4% | 1.9% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 2.6 | 2.5 | 0.6 | 0.5 | 0.7 | 1.0 | 0.6 | 0.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 277,738 | 294,340 | 391,974 | 534,901 | 385,591 | 420,533 | 415,136 | 426,840 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
OneMed - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-01-16 | 2026-01-20 | 3871.69 |
| 2025-05-16 | 2025-05-18 | 4010.46 |
| 2023-05-23 | 2023-05-30 | 5.65 |
| 2023-05-16 | 2023-05-22 | 407.67 |
| 2023-04-18 | 2023-04-26 | 11.88 |
| 2023-01-24 | 2023-01-31 | 0.12 |
| 2022-11-21 | 2022-11-21 | 0.21 |
| 2022-11-17 | 2022-11-18 | 0.21 |
| 2022-10-28 | 2022-10-30 | 0.21 |
| 2022-10-18 | 2022-10-24 | 89.57 |
| 2022-09-16 | 2022-09-28 | 27.38 |
| 2022-08-23 | 2022-08-28 | 22.50 |
OneMed - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
OneMed, UAB (code 111822140) is a Private Limited Liability Company engaged in wholesale of pharmaceutical and medical goods. In the latest financial year, 2025, revenue reached €2.99M, increasing by 2.8% year on year and by 5.3% compared with 2023. Net profit rose to €42.1K, while profit before tax increased to €56.7K. The profit margin improved to 1.4%, up from 1.0% in 2024 and 0.9% in 2023, indicating gradual but still modest profitability. Over the three-year period, the company maintained stable revenue growth and a clear upward trend in earnings. The balance sheet showed a stronger capital structure: equity increased to €724.1K, liabilities dropped sharply to €69.8K, and the equity ratio reached 87.1%, with debt-to-equity at 0.10. Total assets declined to €831.5K, driven mainly by a lower asset base, while short-term assets made up almost all assets. In 2025, asset turnover was 3.59x, ROE was 5.8%, ROA was 5.1%, revenue per employee was €426.8K, and profit per employee was €6.0K.